Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in Western Europe

A Luca, D Dunn, M Zazzi, R Camacho, C Torti, I Fanti, R Kaiser, A Sonnerborg, FM Codoner, K Van Laethem, AM Vandamme, L Bansi, V Ghisetti, David van de Vijver, D Asboe, MCF Prosperi, S Di Giambenedetto

Research output: Contribution to journalArticleAcademicpeer-review

59 Citations (Scopus)

Abstract

HIV-1 drug resistance represents a major obstacle to infection and disease control. This retrospective study analyzes trends and determinants of resistance in antiretroviral treatment (ART)-exposed individuals across 7 countries in Europe. Of 20 323 cases, 80% carried at least one resistance mutation: these declined from 81% in 1997 to 71% in 2008. Predicted extensive 3-class resistance was rare (3.2% considering the cumulative genotype) and peaked at 4.5% in 2005, decreasing thereafter. The proportion of cases exhausting available drug options dropped from 32% in 2000 to 1% in 2008. Reduced risk of resistance over calendar years was confirmed by multivariable analysis.
Original languageUndefined/Unknown
Pages (from-to)1216-1220
Number of pages5
JournalJournal of Infectious Diseases
Volume207
Issue number8
DOIs
Publication statusPublished - 2013

Research programs

  • EMC MM-04-27-01

Cite this